COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...

20 U.S. states (plus D.C.) had "very high" levels of SARS-CoV-2—the virus that causes COVID-19—present in wastewater for the week between December 29, 2024 and January 04, 2025. This is a jump ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

An imbalance in gene activity in two types of immune cells explains why lung fibrosis after a severe COVID-19 infection doesn ...

In sum, the findings illustrate fluoxetine's weak antiviral activity in adults with early symptomatic COVID-19. There were no significant differences in the time to symptom or fever resolution ...

The levels of COVID-19 present in wastewater around the country is on the rise, new data from the U.S. Centers for Disease Control and Prevention (CDC) reveals. 20 U.S. states (plus D.C.) had ...

Seventeen states around the U.S. reported "very high" wastewater levels of SARS-CoV-2—the virus that causes COVID-19—during the week between January 5 and January 11. This is a drop from the ...